Risk-reducing mastectomy in BRCA carriers: survival is not the issue.

Neven, P; Punie, K; Wildiers, H; Willers, N; Van Ongeval, C; Van Buggenhout, G; Legius, E

Neven, P; Punie, K; Wildiers, H; Willers, N; Van Ongeval, C; Van Buggenhout, G; Legius, E.

Afiliación

Neven P; Multidisciplinary Breast Centre and Leuven University Centre for Cancer Prevention (LUCK), University Hospitals Leuven, Louvain, Belgium. Patrick.neven@uzleuven.be.
Punie K; Multidisciplinary Breast Centre and Leuven University Centre for Cancer Prevention (LUCK), University Hospitals Leuven, Louvain, Belgium.
Wildiers H; Multidisciplinary Breast Centre and Leuven University Centre for Cancer Prevention (LUCK), University Hospitals Leuven, Louvain, Belgium.
Willers N; Multidisciplinary Breast Centre and Leuven University Centre for Cancer Prevention (LUCK), University Hospitals Leuven, Louvain, Belgium.
Van Ongeval C; Multidisciplinary Breast Centre and Leuven University Centre for Cancer Prevention (LUCK), University Hospitals Leuven, Louvain, Belgium.
Van Buggenhout G; Department of Human Genetics, University Hospitals Leuven, Louvain, Belgium.
Legius E; Multidisciplinary Breast Centre and Leuven University Centre for Cancer Prevention (LUCK), University Hospitals Leuven, Louvain, Belgium.

Breast Cancer Res Treat ; 179(1): 251-252, 2020 01.

Article en En | MEDLINE | ID: mdl-31541380

Asunto(s)

Genes BRCA2; Mastectomía; Heterocigoto

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Genes BRCA2 / Mastectomía Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google